Ameritas Investment Company’s Bristol-Myers Squibb BMY Stock Holding History

Ameritas Investment Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.01M	Buy	17,052 +12,658	+288%	+$834K	0.05%	272
2021 Q2	$1.08M	Sell	4,394 -18,936	-81%	-$1.23M	0.05%	270
2021 Q1	$1.47M	Buy	+23,330	New	+$1.45M	0.13%	163
2020 Q4	–	Sell	-5,549	Closed	-$326K	–	426
2020 Q3	$326K	Hold	5,549	–	–	0.1%	218
2020 Q2	$326K	Sell	5,549 -3,587	-39%	-$215K	0.09%	224
2020 Q1	$508K	Buy	9,136 +7,434	+437%	+$454K	0.08%	190
2019 Q4	$109K	Sell	1,702 -256	-13%	-$14.7K	0.02%	449
2019 Q3	$106K	Buy	+1,958	New	+$92K	0.02%	466
2019 Q2	–	Sell	-3,569	Closed	-$170K	–	301
2019 Q1	$170K	Buy	+3,569	New	+$178K	0.03%	318

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Ameritas Investment Company's BMY Position: Q3 2021 in Review

Ameritas Investment Company increased its Bristol-Myers Squibb (BMY) stake by 288% in Q3 2021, buying an estimated $834K and bringing the position to 17,052 shares worth $1.01M. The position accounts for 0.05% of the portfolio, ranked #272.

Ameritas Investment Company first reported a position in BMY in Q1 2019 and has held it in 9 quarters since. The position peaked at $1.47M in Q1 2021. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

Ameritas Investment Company held 17,052 shares of Bristol-Myers Squibb worth $1.01M as of Q3 2021.
Ameritas Investment Company bought 12,658 Bristol-Myers Squibb shares in Q3 2021, an estimated $834K.
Bristol-Myers Squibb made up 0.05% of Ameritas Investment Company's portfolio in Q3 2021, its #272 holding.
Ameritas Investment Company first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 9 quarters since.
Ameritas Investment Company's Bristol-Myers Squibb position peaked at $1.47M in Q1 2021.
2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.